Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma.

Ladetto, M; Zallio, F; Vallet, S; Ricca, I; Cuttica, A; Caracciolo, D; Corradini, P; Astolfi, M; Sametti, S; Volpato, F; Bondesan, P; Vitolo, U; Boccadoro, M; Pileri, A; Gianni, A M; Tarella, C

Ladetto, M; Zallio, F; Vallet, S; Ricca, I; Cuttica, A; Caracciolo, D; Corradini, P; Astolfi, M; Sametti, S; Volpato, F; Bondesan, P; Vitolo, U; Boccadoro, M; Pileri, A; Gianni, A M; Tarella, C.

Affiliation

Ladetto M; Divisione Universitaria di Ematologia-Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Torino, Italy.

Leukemia ; 15(12): 1941-9, 2001 Dec.

Article in En | MEDLINE | ID: mdl-11753616

Subject(s)

Antibodies, Monoclonal/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Immunotherapy; Lymphoma, Non-Hodgkin/drug therapy; Adult; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal/toxicity; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols/toxicity; Drug Administration Schedule; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin/complications; Lymphoma, Non-Hodgkin/therapy; Male; Middle Aged; Neoplasm, Residual/diagnosis; Polymerase Chain Reaction; Rituximab; Salvage Therapy; Transplantation, Autologous; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Immunotherapy / Antibodies, Monoclonal Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2001 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links